Safety and efficacy of rivaroxaban compared to warfarin in patients with atrial fibrillation and advanced stages of chronic kidney disease

Back

ESC Premium Access

Safety and efficacy of rivaroxaban compared to warfarin in patients with atrial fibrillation and advanced stages of chronic kidney disease

Session: Cardiovascular Disease in Special Populations ePosters

Topic: Renal Failure and Cardiovascular Disease

Speaker: Doctor M. Chashkina (Moscow, RU)

Event: ESC Congress 2020

Congress Presentation

Add to my library

About the speaker

Doctor Maria Chashkina

I.M. Sechenov First Moscow State Medical University, Moscow (Russian Federation)

0 follower

155 more presentations in this session

Implementation study of CT calcium score in patients with atypical angina pectoris and non-specific thoracic complaints in primary care: rationale, objectives, and design of the CONCRETE study

Speaker: Miss M. Koopman (Groningen, NL)

Access

Abstract

Slides

Serum uric acid possibly associated with abnormal left ventricular diastolic function in healthy individuals

Speaker: Doctor C. Liu (Taipei, TW)

Access

Abstract

Slides

Characteristics and health status of patients with and without confirmed HFpEF

Speaker: Professor C. Deaton (Cambridge, GB)

Access

Abstract

Slides

Evaluating the diagnostic and prognostic value of cardiac biomarkers for heart disease and major adverse cardiac events in patients with muscular dystrophy

Speaker: Mr A. Nikhanj (Edmonton, CA)

Access

Abstract

Slides

Heart involvement in type 1 and type 2 myotonic dystrophy. Insights from a 10-year follow-up study.

Speaker: Doctor F. Fioravanti (Milan, IT)

Access

Abstract

Slides

Access the full session

Cardiovascular Disease in Special Populations ePosters

Speakers: Doctor M. Chashkina, Miss M. Koopman, Doctor C. Liu, Professor C. Deaton, Mr A. Nikhanj...

Access

About the event

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources